Dr. Paul Cherukuri is the Executive Director of the Institute of Biosciences and Bioengineering where he provides leadership for Rice University’s only interdisciplinary institute dedicated to fostering bio-related research innovation among 150 faculty members that span the Schools of Natural Sciences and Engineering. Cherukuri creates strategic research partnerships between Rice University faculty and colleagues in the Department of Defense, NASA, Texas Medical Center, and the Houston business community.
Cherukuri earned his B.S. in Physics from the University of Kentucky and Ph.D. in Chemistry at Rice University under Nobel Laureate Richard E. Smalley. Before returning to Rice, Cherukuri was a senior scientist at Sanofi where he managed the R&D of several brand-name drug products and devices (e.g. Allegra). Prior to Sanofi, he was a Visiting Scholar at Harvard University with Prof. George Whitesides and a Research Assistant Professor of Experimental Therapeutics at the University of Texas MD Anderson Cancer Center.
His research includes directed self-assembly of living and artificial materials (Teslaphoresis), cold plasma therapy, and biosensors. He is a subject matter expert in nanomaterials, directed energy, bioelectronics, drug development, transdisciplinary research, design thinking, entrepreneurship, and technology commercialization.